Search results
Results From The WOW.Com Content Network
Amneal's Generics Division focuses on a broad range of therapeutic areas, including solid oral dosage products and alternative dosage form products. [23] The company's Specialty Pharma Division is focused on the development of proprietary branded pharmaceutical products for the treatment of Central Nervous System disorders, Endocrine disorders ...
Amneal Pharmaceuticals said on Friday it had reached a deal valued at more than $270 million to resolve claims it helped fuel the deadly U.S. opioid epidemic, becoming the latest drug company to ...
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
Discover the latest breaking news in the U.S. and around the world — politics, weather, entertainment, lifestyle, finance, sports and much more.
Actavis Generics [1] (formerly known as Watson Pharmaceuticals and Actavis plc, prior to the acquisition of Irish-based Allergan, Inc.) is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products.
For premium support please call: 800-290-4726 more ways to reach us more ways to reach us
Leiner Health Products; Lexicon Pharmaceuticals; Ligand Pharmaceuticals; List of biotech and pharmaceutical companies in the New York metropolitan area; Locus Biosciences; Lundbeck Seattle Biopharmaceuticals; Lykos Therapeutics
In its January 2025 announcement, the FDA gave food companies until January 15, 2027, and ingested drug manufacturers until January 18, 2028, to reformulate their products to comply with the ...